Ownership history in 22NW, LP · 5 quarters on record
This page tracks every 13F SEC filing in which 22NW, LP reported a position in NEKTAR THERAPEUTICS (NKTR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 331,115 | — | 0% | 5.89% | $14.0M | $42.28 |
| 2025 Q3 | ADDED | 331,115 | +185,000 | +126.6% | 8.88% | $18.8M | $56.90 |
| 2025 Q2 | REDUCED | 146,115 | -2,045,635 | -93.3% | 2.38% | $3.8M | $25.84 |
| 2025 Q1 | UNCHANGED | 2,191,750 | — | 0% | 1.00% | $1.5M | $10.20 |
As of 2025 Q4 — sorted by position size